K-lyte/cl Generic Name & Formulations
Potassium (as chloride) 25mEq; effervescent tabs for soln; citrus and fruit-punch flavor.
K-Lyte/Cl tabs—30, 100, 250; K-Lyte/Cl 50 tabs—30, 100
Hypokalemia, including that caused by diuretics. Digitalis intoxication without AV block.
K-lyte/cl Dosage and Administration
Prophylaxis: 25mEq daily. Treatment: 50–100mEq daily in divided doses. Both, dissolve each tab in 6–8oz of water and sip slowly over 5–10 minutes after meals.
Hyperkalemia. Chronic renal disease. Acute dehydration. Heat cramps. Severe tissue destruction. Adrenal insufficiency. Familial periodic paralysis. Acidosis (potassium chloride products). Alkalosis (potassium bicarbonate products). Tablets: Esophageal compression due to enlarged left atrium. Decreased GI motility.
K-lyte/cl Boxed Warnings
Discontinue if GI bleed, ulceration, or other disturbances occur. Renal or cardiac disease. Monitor potassium level, clinical status, acid-base balance, and ECG. Elderly. Pregnancy (Cat.C). Nursing mothers.
Hyperkalemia with ACE inhibitors, spironolactone, triamterene, amiloride, and potassium-containing salt substitutes. Anticholinergics, other agents that decrease GI motility increase risk of serious GI reactions with tablets.
K-lyte/cl Adverse Reactions
Hyperkalemia, GI discomfort and irritation, diarrhea, rash (rare). Tablets: Esophageal and GI ulceration, bleeding, obstruction, perforation.
K-lyte/cl Clinical Trials
K-lyte/cl Patient Counseling